Blinded Enalapril


Combined with:

Blinded NO Treatment Received

Indications and Reactions:

Role Indications Reactions
Primary
Cardiac Failure Chronic 59.1%
Cardiac Failure 8.6%
Prophylaxis 4.7%
Atrial Fibrillation 4.3%
Cardiac Failure Congestive 3.4%
Hypertension 2.6%
Myocardial Ischaemia 2.6%
Coronary Artery Disease 1.7%
Diabetes Mellitus 1.7%
Hyperlipidaemia 1.7%
Blood Pressure Increased 1.3%
Parkinson's Disease 1.3%
Anticoagulant Therapy 0.9%
Antiplatelet Therapy 0.9%
Arrhythmia 0.9%
Cardiovascular Event Prophylaxis 0.9%
Depression 0.9%
Insomnia 0.9%
Myocardial Infarction 0.9%
Oedema 0.9%
Cardiac Failure 14.8%
Renal Failure Acute 11.1%
Ventricular Tachycardia 11.1%
Cardiac Failure Congestive 3.7%
Cerebrovascular Accident 3.7%
Concomitant Disease Progression 3.7%
Coronary Artery Disease 3.7%
Cough 3.7%
Disease Progression 3.7%
Generalised Anxiety Disorder 3.7%
Hyperkalaemia 3.7%
Intestinal Ischaemia 3.7%
Myocardial Ischaemia 3.7%
Oedema Peripheral 3.7%
Pancreatitis Acute 3.7%
Pneumonia Aspiration 3.7%
Pulmonary Oedema 3.7%
Renal Failure Chronic 3.7%
Renal Impairment 3.7%
Rhabdomyolysis 3.7%
Secondary
Cardiac Failure 51.1%
Cardiac Failure Chronic 18.8%
Prophylaxis 3.5%
Cardiac Failure Congestive 3.2%
Myocardial Ischaemia 3.2%
Chronic Obstructive Pulmonary Disease 2.6%
Diabetes Mellitus 2.3%
Angina Pectoris 1.8%
Atrial Fibrillation 1.5%
Glaucoma 1.5%
Cerebral Artery Embolism 1.4%
Hypertension 1.3%
Anaemia 1.1%
Coronary Artery Disease 1.1%
Drug Therapy 1.0%
Dyslipidaemia 1.0%
Prostatism 1.0%
Insomnia 0.9%
Constipation 0.9%
Nasopharyngitis 0.9%
Urinary Tract Infection 12.3%
Cardiac Failure 11.4%
Ventricular Tachycardia 8.8%
Hypotension 7.0%
Coronary Artery Disease 6.1%
Vomiting 6.1%
Vertigo 5.3%
Dyspnoea 4.4%
Gastrointestinal Haemorrhage 4.4%
Pneumonia 4.4%
Atrial Flutter 3.5%
Orthostatic Hypotension 3.5%
Renal Failure Acute 3.5%
Thrombocytopenia 3.5%
Anaemia 2.6%
Blood Potassium Increased 2.6%
Coronary Artery Stenosis 2.6%
Dizziness 2.6%
Hernia Repair 2.6%
Renal Impairment 2.6%

Drug Data